These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19615849)

  • 1. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures.
    Saxena A; Yan TD; Morris DL
    Eur J Surg Oncol; 2010 Mar; 36(3):309-14. PubMed ID: 19615849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
    Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures.
    Saxena A; Yan TD; Chua TC; Fransi S; Almohaimeed K; Ahmed S; Morris DL
    Ann Surg Oncol; 2009 Aug; 16(8):2195-203. PubMed ID: 19408046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment.
    Chua TC; Saxena A; Schellekens JF; Liauw W; Yan TD; Fransi S; Zhao J; Morris DL
    Ann Surg; 2010 Jan; 251(1):101-6. PubMed ID: 19838105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
    Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: incidence, risk factors, management, and clinical sequelae.
    Saxena A; Chua TC; Yan TD; Morris DL
    Ann Surg Oncol; 2010 May; 17(5):1302-10. PubMed ID: 20087784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
    Yan TD; Zappa L; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    J Surg Oncol; 2007 Aug; 96(2):102-12. PubMed ID: 17221852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
    Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
    Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center.
    Yan TD; Links M; Fransi S; Jacques T; Black D; Saunders V; Morris DL
    Ann Surg Oncol; 2007 Aug; 14(8):2270-80. PubMed ID: 17464543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    Saxena A; Yan TD; Morris DL
    World J Surg; 2010 Jan; 34(1):70-8. PubMed ID: 19760317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
    Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
    Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
    Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
    Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
    Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.
    Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH
    Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.
    Capone A; Valle M; Proietti F; Federici O; Garofalo A; Petrosillo N
    J Surg Oncol; 2007 Nov; 96(6):507-13. PubMed ID: 17708508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.